CRBU vs EW · rev $3.9M vs P/E 47, rev $3.39B
Caribou Biosciences Inc (CRBU) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Caribou Biosciences Inc (CRBU) is a biotechnology company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported CRBU revenue for 2026-06-30 was $3.9M. Net income was -$49.4M. Revenue was up 62.5% from 2026-03-31 to 2026-06-30. CRBU currently screens at market cap $190.4M.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
CRBU currently screens at market cap $190.4M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the CRBU and EW stock pages for the full models.
Not investment advice.